Brünner N - Search Results

1

Serum cystatin C, a new marker of glomerular filtration rate, is increased during malignant progression.

Kos J, Stabuc B, Cimerman N, Brünner N. Kos J, et al. Among authors: brunner n. Clin Chem. 1998 Dec;44(12):2556-7. Clin Chem. 1998. PMID: 9836733 Review. No abstract available.

2

Cysteine proteinase inhibitors stefin A, stefin B, and cystatin C in sera from patients with colorectal cancer: relation to prognosis.

Kos J, Krasovec M, Cimerman N, Nielsen HJ, Christensen IJ, Brünner N. Kos J, et al. Among authors: brunner n. Clin Cancer Res. 2000 Feb;6(2):505-11. Clin Cancer Res. 2000. PMID: 10690531

3

Cathepsin B/cystatin C complex levels in sera from patients with lung and colorectal cancer.

Zore I, Krasovec M, Cimerman N, Kuhelj R, Werle B, Nielsen HJ, Brünner N, Kos J. Zore I, et al. Among authors: brunner n. Biol Chem. 2001 May;382(5):805-10. doi: 10.1515/BC.2001.097. Biol Chem. 2001. PMID: 11517934

4

Prognostic values of cathepsin B and carcinoembryonic antigen in sera of patients with colorectal cancer.

Kos J, Nielsen HJ, Krasovec M, Christensen IJ, Cimerman N, Stephens RW, Brünner N. Kos J, et al. Among authors: brunner n. Clin Cancer Res. 1998 Jun;4(6):1511-6. Clin Cancer Res. 1998. PMID: 9626470

5

Serum cathepsin H as a potential prognostic marker in patients with colorectal cancer.

Schweiger A, Christensen IJ, Nielsen HJ, Sørensen S, Brünner N, Kos J. Schweiger A, et al. Among authors: brunner n. Int J Biol Markers. 2004 Oct-Dec;19(4):289-94. doi: 10.1177/172460080401900406. Int J Biol Markers. 2004. PMID: 15646835 Free article.

6

Cysteine proteinases and their inhibitors in extracellular fluids: markers for diagnosis and prognosis in cancer.

Kos J, Werle B, Lah T, Brunner N. Kos J, et al. Among authors: brunner n. Int J Biol Markers. 2000 Jan-Mar;15(1):84-9. doi: 10.1177/172460080001500116. Int J Biol Markers. 2000. PMID: 10763147 Free article. Review.

7

Determination of the complex between urokinase and its type-1 inhibitor in plasma from healthy donors and breast cancer patients.

Pedersen AN, Brünner N, Høyer-Hansen G, Hamer P, Jarosz D, Larsen B, Nielsen HJ, Stephens RW. Pedersen AN, et al. Among authors: brunner n. Clin Chem. 1999 Aug;45(8 Pt 1):1206-13. Clin Chem. 1999. PMID: 10430786

8

Plasma tissue inhibitor of metalloproteinases-1 as a biological marker? Pre-analytical considerations.

Lomholt AF, Frederiksen CB, Christensen IJ, Brünner N, Nielsen HJ. Lomholt AF, et al. Among authors: brunner n. Clin Chim Acta. 2007 May 1;380(1-2):128-32. doi: 10.1016/j.cca.2007.01.022. Epub 2007 Feb 1. Clin Chim Acta. 2007. PMID: 17328880

9

Measurement of the noncomplexed free fraction of tissue inhibitor of metalloproteinases 1 in plasma by immunoassay.

Holten-Andersen MN, Christensen IJ, Nielsen HJ, Lilja H, Murphy G, Jensen V, Brünner N, Piironen T. Holten-Andersen MN, et al. Among authors: brunner n. Clin Chem. 2002 Aug;48(8):1305-13. Clin Chem. 2002. PMID: 12142388

10

National Academy of Clinical Biochemistry laboratory medicine practice guidelines for use of tumor markers in testicular, prostate, colorectal, breast, and ovarian cancers.

Sturgeon CM, Duffy MJ, Stenman UH, Lilja H, Brünner N, Chan DW, Babaian R, Bast RC Jr, Dowell B, Esteva FJ, Haglund C, Harbeck N, Hayes DF, Holten-Andersen M, Klee GG, Lamerz R, Looijenga LH, Molina R, Nielsen HJ, Rittenhouse H, Semjonow A, Shih IeM, Sibley P, Sölétormos G, Stephan C, Sokoll L, Hoffman BR, Diamandis EP; National Academy of Clinical Biochemistry. Sturgeon CM, et al. Among authors: brunner n. Clin Chem. 2008 Dec;54(12):e11-79. doi: 10.1373/clinchem.2008.105601. Clin Chem. 2008. PMID: 19042984

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

594 results

Search Page

Filters